-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Galectin Therapeutics Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2020 to Q2 2024.
- Galectin Therapeutics Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $737K, a 42.8% increase year-over-year.
- Galectin Therapeutics Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $2.42M, a 4.57% decline year-over-year.
- Galectin Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2023 was $2.26M, a 21.1% decline from 2022.
- Galectin Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2022 was $2.87M, a 38.1% increase from 2021.
- Galectin Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2021 was $2.08M, a 15.4% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)